Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 days
Awards & highlights
Study Summary
The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 120 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Best-corrected visual acuity by ETDRS
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
Group II: 2Placebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Chakshu Research, Inc.Lead Sponsor
3 Previous Clinical Trials
113 Total Patients Enrolled
1 Trials studying Cataract
81 Patients Enrolled for Cataract
Ira Wong, MDStudy DirectorChakshu Research, Inc.
2 Previous Clinical Trials
32 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What site did they apply to?
Hunkeler Eye Institute
What portion of applicants met pre-screening criteria?
Met criteria
Why did patients apply to this trial?
I have been referred for cataract surgery, but would prefer a nonsurgical treatment option.
PatientReceived no prior treatments
What questions have other patients asked about this trial?
How long do visits take?
How long is the trial?
What are the risk & possible side effects?
PatientReceived 1 prior treatment
Recent research and studies
Share this study with friends
Copy Link
Messenger